ORCID (Optional)
wn785915@ohio.edu
Document Type
Case Report
Disciplines
Anesthesia and Analgesia | Investigative Techniques | Medicine and Health Sciences | Musculoskeletal Diseases | Nervous System | Nervous System Diseases | Other Medical Specialties | Pathological Conditions, Signs and Symptoms | Skin and Connective Tissue Diseases | Therapeutics
Abstract
Introduction: Raynaud’s phenomenon (RP) is predominately a sympathetically mediated ischemic vasospastic disease involving the distal limbs and is associated with sharp pains, numbness, and dermatological color changes. The symptoms are commonly induced by cold weather, stress, and trauma and it is known to affect 4.85% of the population. There are few well-defined treatments for patients with RP that are refractory to 1st-line therapies. We present a case of intractable RP with corresponding response to stellate ganglion block (SGB) which demonstrates the efficacy profile and safety of SNS blocks in treatment of resistant RP.
Methods: Per Bon Secours Mercy Health IRB policy, this case report does not qualify for Mercy Health North IRB, and a formal statement from them has been attainted.
Results: By week 1, our patient had a reduction in pain (71.4%), duration of symptoms (75%), and frequency (75%), with a simultaneous 66% improvement in severity/dexterity. Our patient showed therapeutic improvement from baseline in duration/frequency until week 6 and pain/severity until week 7.
Conclusion: With minimal significant prospective data on comparative efficacy of various RP intervention options, and a high disease burden in the general population, we highlight the importance of this paper’s findings and the need for further research on this topic.
Methods: Per Bon Secours Mercy Health IRB policy, this case report does not qualify for Mercy Health North IRB, and a formal statement from them has been attainted.
Results: By week 1, our patient had a reduction in pain (71.4%), duration (75%), and frequency (75%), with a simultaneous 66% improvement in severity/dexterity. Our patient showed therapeutic improvement from baseline in Duration/Frequency until Week 6 and Pain/Severity until Week 7.
Conclusion: With minimal significant prospective data on comparative efficacy of various RP intervention options, and a high disease burden in the general population, we highlight the importance of this paper’s findings and the need for further research on this topic.
DOI
https://doi.org/10.32873/unmc.dc.gmerj.5.1.007
Keywords
Raynaud's Phenomenon, Stellate Ganglion Block, Fluoroscopy
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Recommended Citation
Naber, W. J., Scribner, D. J., , Howard, G. Stellate Ganglion Block for refractory Raynaud’s Phenomenon- A Case Report. Graduate Medical Education Research Journal. 2023 Jun 30; 5(1).
https://digitalcommons.unmc.edu/gmerj/vol5/iss1/7
Included in
Anesthesia and Analgesia Commons, Investigative Techniques Commons, Musculoskeletal Diseases Commons, Nervous System Commons, Nervous System Diseases Commons, Other Medical Specialties Commons, Pathological Conditions, Signs and Symptoms Commons, Skin and Connective Tissue Diseases Commons, Therapeutics Commons
